Depression as a Microglial Disease

Trends in Neurosciences

Volumn 38, Issue 10, 2015, Pages 637-658

  Yirmiya, Raz ^a   Rimmerman, Neta ^a   Reshef, Ronen ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Antidepressants; Depression; Inflammation; Microglia; Neurogenesis; Stress

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELECOXIB; CITALOPRAM; CORTICOSTERONE; CYCLOOXYGENASE 1 INHIBITOR; DESIPRAMINE; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGING; ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; CELL AGING; CEREBROVASCULAR ACCIDENT; CHRONIC UNPREDICTABLE STRESS; DEPRESSION; ELECTROCONVULSIVE THERAPY; HOMEOSTASIS; HUMAN; INFECTION; INJURY; MAJOR DEPRESSION; MICROGLIA; MICROGLIAL DISEASE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; ANIMAL; DEPRESSIVE DISORDER; DRUG EFFECTS; IMMUNOLOGY; PERSONALIZED MEDICINE; PROCEDURES;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; HUMANS; MICROGLIA; PRECISION MEDICINE;

EID: 84943234818     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2015.08.001     Document Type: Review

References (200)

1. Halassa M.M., Haydon P.G. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu. Rev. Physiol. 2010, 72:335-355.
2. Kettenmann H., et al. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
3. Tremblay M.E., et al. The role of microglia in the healthy brain. J. Neurosci. 2011, 31:16064-16069.
4. Maes M., et al. The inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24:27-53.
5. Frick L.R., et al. Microglial dysregulation in psychiatric disease. Clin. Dev. Immunol. 2013, 2013:608654.
6. Beumer W., et al. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J. Leukoc. Biol. 2012, 92:959-975.
7. Prinz M., Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 2014, 15:300-312.
8. Wake H., et al. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci. 2013, 36:209-217.
9. Yirmiya R., et al. Cytokines, 'depression due to a general medical condition' and antidepressant drugs. Adv. Exp. Med. Biol. 1999, 461:283-316.
10. Rock R.B., et al. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 2004, 17:942-964.
11. Vollmer-Conna U., et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol. Med. 2004, 34:1289-1297.
12. Dowlati Y., et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
13. Haapakoski R., et al. Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav. Immun. 2015, Published online June 9, 2015. 10.1016/j.bbi.2015.06.001.
14. Reichenberg A., et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58:445-452.
15. Grigoleit J.S., et al. Dose-dependent effects of endotoxin on neurobehavioral functions in humans. PLoS ONE 2011, 6:e28330.
16. Harrison N.A., et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry 2009, 66:407-414.
17. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996, 711:163-174.
18. Yirmiya R., et al. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 2001, 24:531-544.
19. Henry C.J., et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflamm. 2008, 5:15.
20. O'Connor J.C., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14:511-522.
21. O'Connor J.C., et al. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J. Neurosci. 2009, 29:4200-4209.
22. Dobos N., et al. The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J. Alzheimers Dis. 2012, 28:905-915.
23. Corona A.W., et al. Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice. Brain Behav. Immun. 2013, 31:134-142.
24. Fenn A.M., et al. Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia. Biol. Psychiatry 2014, 76:575-584.
25. Del Guerra F.B., et al. Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. J. Neurovirol. 2013, 19:314-327.
26. Kaul M., et al. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994.
27. Barreto I.C., et al. Animal models for depression associated with HIV-1 infection. J. Neuroimmune Pharmacol. 2013, 9:125-208.
28. Barak O., et al. Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120. Brain Res. 2002, 933:98-108.
29. Barak O., et al. Intracerebral HIV-1 glycoprotein 120 produces sickness behavior and pituitary-adrenal activation in rats: role of prostaglandins. Brain Behav. Immun. 2002, 16:720-735.
30. Lawson M.A., et al. Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. Brain Behav. Immun. 2011, 25:1569-1575.
31. Bayer T.A., et al. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci. Lett. 1999, 271:126-128.
32. Steiner J., et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 2008, 42:151-157.
33. Torres-Platas S.G., et al. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav. Immun. 2014, 42:50-59.
34. Schnieder T.P., et al. Microglia of prefrontal white matter in suicide. J. Neuropathol. Exp. Neurol. 2014, 73:880-890.
35. Foster R., et al. Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process?. Eur. J. Neurosci. 2006, 24:3561-3566.
36. Rupprecht R., et al. Translocator protein (18kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 2010, 9:971-988.
37. 11C]PBR28 PET study. Brain Behav. Immun. 2013, 33:131-138.
38. Setiawan E., et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 2015, 72:268-275.
39. 11C]-(R)-PK11195 positron emission tomography study. Brain Behav. Immun. 2014, 40:219-225.
40. Colasanti A., et al. TSPO-targeted PET imaging suggests increased microglia activation in multiple sclerosis hippocampus is correlated to depressive symptomatology. Biol. Psychiatry 2014, 75:94-95.
41. Goshen I., Yirmiya R. Interleukin-1 (IL-1): a central regulator of stress responses. Front. Neuroendocrinol. 2009, 30:30-45.
42. Kendler K.S., et al. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry 1999, 156:837-841.
43. Kreisel T., et al. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol. Psychiatry 2014, 19:699-709.
44. Sugama S., et al. Differential microglial activation between acute stress and lipopolysaccharide treatment. J. Neuroimmunol. 2009, 207:24-31.
45. Sugama S., et al. Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18. Neuroscience 2007, 146:1388-1399.
46. Frank M.G., et al. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav. Immun. 2007, 21:47-59.
47. Frank M.G., et al. Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain Behav. Immun. 2012, 26:337-345.
48. Blandino P., et al. The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1beta responses to stress. J. Neuroimmunol. 2006, 173:87-95.
49. Nair A., Bonneau R.H. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J. Neuroimmunol. 2006, 171:72-85.
50. Kwon M.S., et al. The repeated immobilization stress increases IL-1beta immunoreactivities in only neuron, but not astrocyte or microglia in hippocampal CA1 region, striatum and paraventricular nucleus. Neurosci. Lett. 2008, 430:258-263.
51. Wohleb E.S., et al. Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology 2012, 37:1491-1505.
52. Wohleb E.S., et al. β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 2011, 31:6277-6288.
53. Wohleb E.S., et al. Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior. J. Neurosci. 2014, 34:2583-2591.
54. Wohleb E.S., et al. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. Neurosci. 2013, 33:13820-13833.
55. Brevet M., et al. Chronic foot-shock stress potentiates the influx of bone marrow-derived microglia into hippocampus. J. Neurosci. Res. 2010, 88:1890-1897.
56. Ataka K., et al. Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice. PLoS ONE 2013, 8:e81744.
57. Kongsui R., et al. Chronic stress induces prolonged suppression of the P2X7 receptor within multiple regions of the hippocampus: a cumulative threshold spectra analysis. Brain Behav. Immun. 2014, 42:69-80.
58. Hinwood M., et al. Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb. Cortex 2012, 22:1442-1454.
59. Tynan R.J., et al. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav. Immun. 2010, 24:1058-1068.
60. Hinwood M., et al. Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline. Cereb. Cortex 2012, 23:1784-1797.
61. Pan Y., et al. Microglial NLRP3 inflammasome activation mediates IL-1beta-related inflammation in prefrontal cortex of depressive rats. Brain Behav. Immun. 2014, 41:90-100.
62. de Pablos R.M., et al. Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation. J. Neuroinflamm. 2014, 11:34.
63. Park J.H., et al. Comparison of glucocorticoid receptor and ionized calcium-binding adapter molecule 1 immunoreactivity in the adult and aged gerbil hippocampus following repeated restraint stress. Neurochem. Res. 2011, 36:1037-1045.
64. Kopp B.L., et al. Differential effects of homotypic vs. heterotypic chronic stress regimens on microglial activation in the prefrontal cortex. Physiol. Behav. 2013, 122:246-252.
65. Heim C., Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 2001, 49:1023-1039.
66. Bilbo S.D., Schwarz J.M. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front. Behav. Neurosci. 2009, 3:14.
67. Ganguly P., Brenhouse H.C. Broken or maladaptive? Altered trajectories in neuroinflammation and behavior after early life adversity. Dev. Cogn. Neurosci. 2015, 11:18-30.
68. Diz-Chaves Y., et al. Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J. Neuroinflamm. 2012, 9:71.
69. Takatsuru Y., et al. Early-life stress increases the motility of microglia in adulthood. J. Physiol. Sci. 2015, 65:187-194.
70. Brenhouse H.C., Thompson V. Maternal separation increases IBA-1 expression: a microglia activation marker in the prefrontal cortex of adolescent males following a second hit of stress. Biol. Psychiatry 2015, 77:52s.
71. Walker F.R. A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?. Neuropharmacology 2013, 67:304-317.
72. Hashioka S., et al. Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp. Neurol. 2007, 206:33-42.
73. Horikawa H., et al. Inhibitory effects of SSRIs on IFN-gamma induced microglial activation through the regulation of intracellular calcium. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:1306-1316.
74. Hwang J., et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 2008, 55:826-834.
75. Liu D., et al. Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells. Neuropharmacology 2011, 61:592-599.
76. Obuchowicz E., et al. Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture. Pharmacol. Rep. 2014, 66:34-43.
77. Bielecka A.M., et al. Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 382:409-417.
78. Tynan R.J., et al. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav. Immun. 2012, 26:469-479.
79. Lim C.M., et al. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J. Neurosci. Res. 2009, 87:1037-1045.
80. Dhami K.S., et al. Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult. Mol. Cell. Neurosci. 2013, 56:365-374.
81. Kohler O., et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 2014, 71:1381-1391.
82. Eyre H.A., et al. A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2015, 57:11-16.
83. Levine J., et al. Possible antidepressant effect of minocycline. Am. J. Psychiatry 1996, 153:582.
84. Miyaoka T., et al. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 37:222-226.
85. Soczynska J.K., et al. Novel therapeutic targets in depression: minocycline as a candidate treatment. Behav. Brain Res. 2012, 235:302-317.
86. Molina-Hernandez M., et al. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:380-386.
87. Deak T., et al. Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behav. Brain Res. 2005, 160:125-134.
88. Zheng L.S., et al. Minocycline treatment ameliorates interferon-alpha- induced neurogenic defects and depression-like behaviors in mice. Front. Cell. Neurosci. 2015, 9:5.
89. Arakawa S., et al. Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline. Pharmacol. Biochem. Behav. 2012, 100:601-606.
90. Burke N.N., et al. Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression. Brain Behav. Immun. 2014, 42:147-156.
91. Quan N., Banks W.A. Brain-immune communication pathways. Brain Behav. Immun. 2007, 21:727-735.
92. Maier S.F., Watkins L.R. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 1998, 105:83-107.
93. Schwartz M., Shechter R. Protective autoimmunity functions by intracranial immunosurveillance to support the mind: the missing link between health and disease. Mol. Psychiatry 2010, 15:342-354.
94. Kipnis J., et al. Pro-cognitive properties of T cells. Nat. Rev. Immunol. 2012, 12:663-669.
95. Sorrells S.F., Sapolsky R.M. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav. Immun. 2007, 21:259-272.
96. Frank M.G., et al. Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav. Immun. 2015, 48:1-7.
97. Touma C., et al. FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol. Psychiatry 2011, 70:928-936.
98. Pandey G.N., et al. Region-specific alterations in glucocorticoid receptor expression in the postmortem brain of teenage suicide victims. Psychoneuroendocrinology 2013, 38:2628-2639.
99. Erny D., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 2015, 18:965-977.
100. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012, 13:701-712.
101. Foster J.A., McVey Neufeld K.A. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013, 36:305-312.
102. Maslanik T., et al. The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure. Brain Behav. Immun. 2013, 28:54-62.
103. Weber M.D., et al. Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague-Dawley rats: a priming stimulus of microglia and the NLRP3 inflammasome. J. Neurosci. 2015, 35:316-324.
104. Lively S., Schlichter L.C. The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion. J. Neuroinflamm. 2013, 10:75.
105. Domenici E., et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS ONE 2010, 5:e9166.
106. Johnson J.D., Fleshner M. Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72. J. Leukoc. Biol. 2006, 79:425-434.
107. Maeng S., et al. BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8766-8771.
108. Pae C.U., et al. Investigation of an epistastic effect between a set of TAAR6 and HSP-70 genes variations and major mood disorders. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2010, 153B:680-683.
109. Goshen I., et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry 2008, 13:717-728.
110. Koo J.W., Duman R.S. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:751-756.
111. Pocock J.M., Kettenmann H. Neurotransmitter receptors on microglia. Trends Neurosci. 2007, 30:527-535.
112. Jacobs B.L., et al. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 2000, 5:262-269.
113. Sahay A., Hen R. Adult hippocampal neurogenesis in depression. Nat. Neurosci. 2007, 10:1110-1115.
114. Sierra A., et al. Surveillance, phagocytosis, and inflammation: how never-resting microglia influence adult hippocampal neurogenesis. Neural Plast. 2014, 2014:610343.
115. Kempermann G., Neumann H. Microglia: the enemy within?. Science 2003, 302:1689-1690.
116. Ekdahl C.T. Microglial activation - tuning and pruning adult neurogenesis. Front. Pharmacol. 2012, 3:41.
117. Ekdahl C.T., et al. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13632-13637.
118. Monje M.L., et al. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
119. Cacci E., et al. Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 2005, 80:789-797.
120. Maes M., et al. Targeting IL-1 in depression. Expert Opin. Ther. Targets 2012, 16:1097-1112.
121. Ben Menachem-Zidon O., et al. Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis. Neuropsychopharmacology 2008, 33:2251-2262.
122. Liu M., et al. Microglia activation regulates GluR1 phosphorylation in chronic unpredictable stress-induced cognitive dysfunction. Stress 2015, 18:96-106.
123. Dantzer R., et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
124. Pollak Y., Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Int. J. Neuropsychopharmacol. 2002, 5:389-399.
125. Walker A.K., et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology 2013, 38:1609-1616.
126. Dantzer R., et al. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
127. Kiank C., et al. Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans. PLoS ONE 2010, 5:e11825.
128. Kanai M., et al. Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol. Brain 2009, 2:8.
129. Capuron L., et al. Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol. Psychiatry 2003, 54:906-914.
130. Bonaccorso S., et al. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J. Clin. Psychopharmacol. 2002, 22:86-90.
131. Capuron L., et al. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 2002, 7:468-473.
132. Gabbay V., et al. The possible role of the kynurenine pathway in anhedonia in adolescents. J. Neural Transm. 2012, 119:253-260.
133. Raison C.L., et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol. Psychiatry 2010, 15:393-403.
134. Smith A.K., et al. Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-alpha-induced depression in patients with chronic hepatitis C. Mol. Psychiatry 2012, 17:781-789.
135. Cutler J.A., et al. Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder. J. Psychopharmacol. 2012, 26:360-367.
136. Steiner J., et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?. J. Neuroinflamm. 2011, 8:94.
137. Aan Het Rot M., et al. Ketamine for depression: where do we go from here?. Biol. Psychiatry 2012, 72:537-547.
138. Almeida O.P., et al. Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int. J. Epidemiol. 2009, 38:1049-1059.
139. Lehto S.M., et al. Serum IL-7 and G-CSF in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:846-851.
140. Lehto S.M., et al. Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology 2010, 35:226-232.
141. Whooley M.A., et al. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol. Psychiatry 2007, 62:314-320.
142. Carboni L., et al. Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:1037-1048.
143. Ongur D., et al. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13290-13295.
144. Cotter D., et al. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 2001, 58:545-553.
145. Cotter D.R., et al. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res. Bull. 2001, 55:585-595.
146. Beekman A.T., et al. Major and minor depression in later life: a study of prevalence and risk factors. J. Affect. Disord. 1995, 36:65-75.
147. Lyketsos C.G., et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch. Gen. Psychiatry 2003, 60:737-746.
148. Hannestad J., et al. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011, 36:2452-2459.
149. Warner-Schmidt J.L., et al. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9262-9267.
150. Chung H.S., et al. Phenelzine (monoamine oxidase inhibitor) increases production of nitric oxide and proinflammatory cytokines via the NF-kappaB pathway in lipopolysaccharide-activated microglia cells. Neurochem. Res. 2012, 37:2117-2124.
151. The APA Task Force on Electroconvulsive Therapy The Practice of Electroconvulsive Therapy. Recommendations for Treatment, Training, and Privileging 2001, American Psychiatric Association.
152. Lehtimaki K., et al. Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J. ECT 2008, 24:88-91.
153. Hestad K.A., et al. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J. ECT 2003, 19:183-188.
154. Roman A., Nalepa I. Effect of repeated administration of paroxetine and electroconvulsive shock on the proliferative response of lymphocytes and the synthesis of nitric oxide by macrophages in rats. J. ECT 2005, 21:111-117.
155. Devi R.S., et al. Modulation of non-specific immunity by hippocampal stimulation. J. Neuroimmunol. 1993, 42:193-197.
156. Wennstrom M., et al. Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol. Psychiatry 2006, 59:178-186.
157. Wennstrom M., et al. Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat hippocampus. Biol. Psychiatry 2003, 54:1015-1024.
158. Jansson L., et al. Glial cell activation in response to electroconvulsive seizures. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1119-1128.
159. Jinno S., Kosaka T. Reduction of Iba1-expressing microglial process density in the hippocampus following electroconvulsive shock. Exp. Neurol. 2008, 212:440-447.
160. Rueger M.A., et al. Multi-session transcranial direct current stimulation (tDCS) elicits inflammatory and regenerative processes in the rat brain. PLoS ONE 2012, 7:e43776.
161. Perez-Caballero L., et al. Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs. Mol. Psychiatry 2014, 19:607-614.
162. Thompson M., Percy J.S. Further experience with indomethacin in the treatment of rheumatic disorders. Br. Med. J. 1966, 1:80-83.
163. Goodwin J.S., Regan M. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum. 1982, 25:1013-1015.
164. Jiang H.K., Chang D.M. Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: five case reports. Clin. Rheumatol. 1999, 18:339-345.
165. Browning C.H. Nonsteroidal anti-inflammatory drugs and severe psychiatric side effects. Int. J. Psychiatry Med. 1996, 26:25-34.
166. Choi S.H., et al. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol. Sci. 2009, 30:174-181.
167. Raison C.L., et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013, 70:31-41.
168. Bauer J., et al. Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol. Psychiatry 1995, 38:611-621.
169. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007, 21:153-160.
170. Rothermundt M., et al. Inflammatory markers in major depression and melancholia. J. Affect. Disord. 2001, 63:93-102.
171. Rothermundt M., et al. Different immune patterns in melancholic and non-melancholic major depression. Eur. Arch. Psychiatry Clin. Neurosci. 2001, 251:90-97.
172. Ginhoux F., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
173. Ajami B., et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 2007, 10:1538-1543.
174. Schafer D.P., et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
175. Paolicelli R.C., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333:1456-1458.
176. Tremblay M.E., et al. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010, 8:e1000527.
177. Parkhurst C.N., et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 2013, 155:1596-1609.
178. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
179. Heneka M.T., et al. Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol. 2014, 14:463-477.
180. Heppner F.L., et al. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 2015, 16:358-372.
181. Streit W.J. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006, 29:506-510.
182. Mosher K.A., Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer's disease. Biochem. Pharmacol. 2014, 88:594-604.
183. Skaper S.D., et al. The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J. 2010, 24:337-345.
184. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
185. Sierra A., et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 2010, 7:483-495.
186. Lu Z., et al. Phagocytic activity of neuronal progenitors regulates adult neurogenesis. Nat. Cell Biol. 2011, 13:1076-1083.
187. Butovsky O., et al. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. 2006, 31:149-160.
188. Battista D., et al. Neurogenic niche modulation by activated microglia: transforming growth factor beta increases neurogenesis in the adult dentate gyrus. Eur. J. Neurosci. 2006, 23:83-93.
189. Walton N.M., et al. Microglia instruct subventricular zone neurogenesis. Glia 2006, 54:815-825.
190. Aarum J., et al. Migration and differentiation of neural precursor cells can be directed by microglia. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15983-15988.
191. Nikolakopoulou A.M., et al. Activated microglia enhance neurogenesis via trypsinogen secretion. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:8714-8719.
192. Goings G.E., et al. Differential activation of microglia in neurogenic versus non-neurogenic regions of the forebrain. Glia 2006, 54:329-342.
193. Reshef R., et al. Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis. Brain Behav. Immun. 2014, 41:239-250.
194. Ziv Y., et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 2006, 9:268-275.
195. Coull J.A., et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021.
196. Batchelor P.E., et al. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 1999, 19:1708-1716.
197. Miwa T., et al. Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J. Neurosci. Res. 1997, 50:1023-1029.
198. Gomes C., et al. Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia. J. Neuroinflamm. 2013, 10:16.
199. Trang T., et al. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci. 2009, 29:3518-3528.
200. Southwick S.M., et al. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu. Rev. Clin. Psychol. 2005, 1:255-291.